IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CHSN

Balance Sheet

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023
Cash & Equivalents22.094.111.47
Accounts Receivable2.412.021.94
Inventory0.710.790.58
Total Current Assets27.4713.207.06
Property, Plant & Equipment5.325.015.48
Intangible Assets0.240.14--
Total Non-current Assets24.0925.5229.50
Total Assets51.5638.7236.55
Accounts Payable2.442.121.56
Short-term Debt0.423.090.41
Total Current Liabilities13.7315.7412.46
Long-term Debt4.46--2.00
Total Non-current Liabilities13.2910.9311.97
Total Liabilities27.0226.6724.43
Retained Earnings(0.66)(0.13)0.10
Total Stockholder Equity24.5412.0512.13

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023
Total Revenue8.697.548.81
Cost of Revenue4.824.424.48
Gross Profit3.873.134.33
Selling, General & Admin2.241.461.77
Total Operating Expenses5.063.694.22
Operating Income(1.19)(0.56)0.11
Interest Expense----(0.01)
Pretax Income(0.99)0.090.29
Tax Provision0.060.060.00
Net Income(1.05)0.020.28
Basic EPS(2.87)0.000.03
Diluted EPS(2.87)0.000.03

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023
Operating Cash Flow(0.39)0.810.61
Capital Expenditures--0.030.15
Free Cash Flow*--0.770.46
Investing Cash Flow1.551.40(11.25)
Financing Cash Flow8.580.379.66

* Derived from reported values